These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 24745854)

  • 1. Understanding and preventing drug-drug and drug-gene interactions.
    Tannenbaum C; Sheehan NL
    Expert Rev Clin Pharmacol; 2014 Jul; 7(4):533-44. PubMed ID: 24745854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual variability in clinical effect and tolerability of opioid analgesics - Importance of drug interactions and pharmacogenetics.
    Solhaug V; Molden E
    Scand J Pain; 2017 Oct; 17():193-200. PubMed ID: 29054049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Falls: the adverse drug reaction of the elderly and the impact of pharmacogenetics.
    Just KS; Schneider KL; Schurig M; Stingl JC; Brockmöller J
    Pharmacogenomics; 2017 Aug; 18(13):1281-1297. PubMed ID: 28776468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bench to bedside: Pharmacogenomics, adverse drug interactions, and the cytochrome P450 system.
    Sikka R; Magauran B; Ulrich A; Shannon M
    Acad Emerg Med; 2005 Dec; 12(12):1227-35. PubMed ID: 16282513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects.
    Pilgrim JL; Gerostamoulos D; Drummer OH
    Forensic Sci Med Pathol; 2011 Jun; 7(2):162-84. PubMed ID: 21052868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome p450 part 3: drug interactions: essential concepts and considerations.
    Krau SD
    Nurs Clin North Am; 2013 Dec; 48(4):697-706. PubMed ID: 24295196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug-drug interactions you should know!].
    Voigt N; Ort K; Sossalla S
    Fortschr Neurol Psychiatr; 2019 May; 87(5):320-332. PubMed ID: 31125990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interactions with HMG-CoA reductase inhibitors (statins): the importance of CYP enzymes, transporters and pharmacogenetics.
    Neuvonen PJ
    Curr Opin Investig Drugs; 2010 Mar; 11(3):323-32. PubMed ID: 20178046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life-threatening drug interactions: what the physician needs to know.
    Day RO; Snowden L; McLachlan AJ
    Intern Med J; 2017 May; 47(5):501-512. PubMed ID: 28503886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 Structure, Function and Clinical Significance: A Review.
    Manikandan P; Nagini S
    Curr Drug Targets; 2018; 19(1):38-54. PubMed ID: 28124606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of the mechanisms of the drug-drug interaction from a view of pharmacogenomics].
    Sai Y; Tsuji A
    Nihon Rinsho; 2002 Jan; 60(1):74-80. PubMed ID: 11808342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic predisposition to adverse drug reactions in the intensive care unit.
    Empey PE
    Crit Care Med; 2010 Jun; 38(6 Suppl):S106-16. PubMed ID: 20502164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avoidable drug-gene conflicts and polypharmacy interactions in patients participating in a personalized medicine program.
    Reynolds KK; Pierce DL; Weitendorf F; Linder MW
    Per Med; 2017 May; 14(3):221-233. PubMed ID: 29767587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug-drug Interactions You Should Know!].
    Voigt N; Ort K; Sossalla S
    Pneumologie; 2019 May; 73(5):306-318. PubMed ID: 31083751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quantitative framework and strategies for management and evaluation of metabolic drug-drug interactions in oncology drug development: new molecular entities as object drugs.
    Venkatakrishnan K; Pickard MD; von Moltke LL
    Clin Pharmacokinet; 2010 Nov; 49(11):703-27. PubMed ID: 20923246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug-drug interactions you should know!].
    Voigt N; Ort K; Sossalla S
    Dtsch Med Wochenschr; 2019 Feb; 144(4):264-275. PubMed ID: 30703807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinically relevant adverse drug interactions].
    Martin-Facklam M; Haefeli WE
    Ther Umsch; 2000 Sep; 57(9):579-83. PubMed ID: 11036439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in Toxicological and Pharmacological Responses Mediated by Polymorphic Cytochromes P450 and Related Drug-Metabolizing Enzymes.
    Yamazaki H
    Chem Res Toxicol; 2017 Jan; 30(1):53-60. PubMed ID: 27750412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral antidiabetic drug metabolism: pharmacogenomics and drug interactions.
    Holstein A; Beil W
    Expert Opin Drug Metab Toxicol; 2009 Mar; 5(3):225-41. PubMed ID: 19331589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.